Smith+Nephew orthopedic sales jump 53% in Q2: 5 notes

Smith+Nephew posted growth in all segments of its orthopedics business in the second quarter.

Advertisement

Five notes:

1. Orthopedic sales in the second quarter were $557 million, a 53 percent increase compared to $364 million in the same time last year.

2. Knee implant sales grew 65.5 percent to$226 million in the second quarter. Hip implants hit $161 million, a 43.6 percent increase compared to the same period last year. The trauma and extremities segment grew 44.3 percent with $149 million in sales.

3. Other reconstruction, which includes the Cori joint replacement robot, saw $21 million in sales, a 72 percent year-over-year increase. 

4 The company’s sports medicine joint repair business grew 63.6 percent to$211 million in sales. Arthroscopic enabling technologies grew 53 percent, bringing in $147 in revenue. 

5. Smith+Nephew’s total revenue in the second quarter grew 48.2 percent, and the company posted $1.3 billion, compared to $901 million in the same period last year.

 

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.